[{"NetIncomeLoss_2_Q2_USD":58392000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":-628000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":606000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":545000.0,"TreasuryStockCommonValue_0_Q2_USD":63814000.0,"OperatingLeaseLiability_0_Q2_USD":3505000.0,"MarketableSecuritiesCurrent_0_Q2_USD":346835000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":22631000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":840000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-66210000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":835000.0,"AssetsCurrent_0_Q2_USD":438333000.0,"OperatingLeaseExpense_2_Q2_USD":800000.0,"OperatingLeaseExpense_1_Q2_USD":400000.0,"Liabilities_0_Q2_USD":44125000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":7966000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-148000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":53107000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":25572000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":3112000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1234000.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":7639000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":530000.0,"LossContingencyAccrualProvision_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":385793000.0,"Assets_0_Q2_USD":497823000.0,"ShareBasedCompensation_2_Q2_USD":16407000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3472000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":8228000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":481714000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1486000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":58523000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":52620000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":26497000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3694000.0,"EarningsPerShareBasic_2_Q2_USD":0.51,"EarningsPerShareBasic_1_Q2_USD":0.25,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":123234000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":122756000.0,"AccountsReceivableNetCurrent_0_Q2_USD":22725000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":17062000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":7945000.0,"CommonStockValue_0_Q2_USD":121000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2_Q2_USD":1100000.0,"IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1_Q2_USD":1000000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":7347000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":16536000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":8548000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":362000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":7009000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q2_USD":2309000.0,"CostsAndExpenses_2_Q2_USD":108839000.0,"CostsAndExpenses_1_Q2_USD":53303000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":153193000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-1414000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":58971000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":28857000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1251000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q2_USD":1690000.0,"InterestIncomeDebtSecuritiesAvailableForSaleOperating_2_Q2_USD":72000.0,"OtherAssetsNoncurrent_0_Q2_USD":4536000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_2_Q2_USD":129000.0,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q2_USD":59000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":35470000.0,"AccruedIncomeTaxesNoncurrent_0_Q2_USD":396000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8548000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-27000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-15000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":86455000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":114790000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":115006000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":4200000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":2109000.0,"LiabilitiesCurrent_0_Q2_USD":42243000.0,"AccountsPayableCurrent_0_Q2_USD":6304000.0,"NonoperatingIncomeExpense_2_Q2_USD":2481000.0,"NonoperatingIncomeExpense_1_Q2_USD":1010000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":58523000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5323000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":281000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":5615000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":4.8,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":1088000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-10000000.0,"IncreaseDecreaseInDeferredIncomeTaxes_1_Q2_USD":-4900000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":1100000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q2_shares":1000000.0,"OperatingLeasePayments_2_Q2_USD":812000.0,"OperatingLeasePayments_1_Q2_USD":422000.0,"InventoryNoncurrent_0_Q2_USD":11193000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":-190000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":-170000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":619000.0,"NetIncomeLoss_1_Q2_USD":28327000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":63000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1055000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":530000.0,"EarningsPerShareDiluted_2_Q2_USD":0.48,"InterestReceivableCurrent_0_Q2_USD":1200000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":619000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":189000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-721000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":181812000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":88565000.0,"OperatingIncomeLoss_2_Q2_USD":72973000.0,"OperatingIncomeLoss_1_Q2_USD":35262000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":75454000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":36272000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":275000.0,"InventoryNet_0_Q2_USD":4927000.0,"PreferredStockValue_0_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":10017000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":497823000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5417000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":7000000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1_Q2_USD":3000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2019000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":775000.0,"ProfitLoss_2_Q2_USD":58392000.0,"StockholdersEquity_0_Q2_USD":453698000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":918000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":89000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":26400000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":34837000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":27254000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2797000.0,"EarningsPerShareDiluted_1_Q2_USD":0.23,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":219314000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":463000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]